Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 16,390,000 | 16,390,000 | 0 | $187.50M | $142.76M | 24.97% | -$44.74M |
| Biogen Inc.(BIIB) | 643,000 | 643,000 | 0 | $166.39M | $138.65M | 24.26% | -$27.74M |
| Innoviva, Inc.(INVA) | 7,277,000 | 7,277,000 | 0 | $116.72M | $110.90M | 19.40% | -$5.82M |
| Gilead Sciences, Inc.(GILD) | 1,075,400 | 1,103,282 | +27,882 | $87.12M | $80.82M | 14.14% | -$6.30M |
| Neurocrine Biosciences, Inc.(NBIX) | 470,000 | 346,426 | -123,574 | $61.93M | $47.78M | 8.36% | -$14.15M |
| Amarin Corp PlcADR | 24,850,623 | 24,850,623 | 0 | $21.62M | $22.14M | 3.87% | +$516.9K |
| Cytokinetics, Incorporated(CYTK) | 0 | 300,000 | +300,000 | $0 | $21.03M | 3.68% | +$21.03M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 1,000,000 | 1,094,168 | +94,168 | $5.99M | $5.56M | 0.97% | -$431.6K |
| Vor Biopharma Inc.(VOR) | 618,000 | 618,000 | 0 | $1.39M | $1.46M | 0.26% | +$74.2K |
| Regulus Therapeutics Inc | 185,183 | 185,183 | 0 | $237.0K | $533.3K | 0.09% | +$296.3K |